Summary by Futu AI
Wobio Pharma-B (02142.HK) will hold a board of directors meeting on Wednesday, August 28, 2024, at which time the group's mid-year performance as of June 30, 2024 will be considered and approved. The meeting will be chaired by the company's chairman and executive director, Dr. Wang Jinsong. In addition to reviewing mid-year performance, other matters will also be addressed at this meeting.